Creative Destruction Lab (CDL), a nonprofit that runs 13 startup accelerators across the world, just graduated another swath of early stage companies from its Seattle program.
CDL launched its Seattle hub in 2021. The 9-month accelerator, based at the University of Washington, is unique because it does not take equity from companies and relies on funding from founding members such as the UW and Microsoft.
It also enforces objective-based milestones and checkpoints; if a company is not meeting certain standards, they are booted out.
CDL-Seattle is supported by more than 70 mentors that include founders, investors, and other leaders from across the Pacific Northwest.
The latest cohort, the third to graduate from CDL-Seattle, admitted 40 startups that qualified from a batch of nearly 300 applications. By graduation, there were 17 companies remaining.
Seattle’s CDL program focuses on two sectors: manufacturing and computational health.
The list below includes the companies that just graduated. See past graduates here.
Manufacturing
- Cibotica (Vancouver B.C.), a food preparation robotics company
- DraftAid (Toronto), an automated fabrication drawing software developer
- Enosemi, a silicon photonics company
- Integrate (Seattle), a collaboration and program management software startup
- Muse Engine (New Orleans), a small batch injection molding manufacturer
- Nullspace (Irvine, Calif), a software developer for electromagnetic applications
- OpenSeam (Seattle), a software developer for textile factories
- Phasio (Singapore), a customer collaboration platform for manufacturers
- Plasmotion (Frieberg, Germany), a plasma electrolytic polishing company
Computational health
- 5 Prime Sciences (Montreal), a drug development startup focused on human genetics
- Accipiter Biosciences, still in stealth mode
- CalmWave (Seattle), a software developer focused on reducing noise in the ICU
- Cascade AI (Seattle), an AI employee engagement software startup
- DocNexus (Seattle), a healthcare ecosystem search database platform
- Generable (New York), a drug development startup building disease-specific models
- Sygnomics (Seattle), a personalized oncology startup that predicts patient risk
- TMA Precision Health (Boston), a genomics-powered care navigation platform
